Blood· 2020Q1
Venous thromboembolism in cancer patients: a population-based cohort study
- 707citations
- Q1SCImago
- 2020year
Short summary
The 12-month incidence of venous thromboembolism (VTE) in cancer patients increased from 1.0% in 1997 to 3.4% in 2017, a nearly ninefold higher risk than the general population (2.3% vs. 0.35% in 2017).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Internal Medicine
Internal MedicineMedicine